Shayan Moosa, Md

This early-stage study tests a new treatment for people whose glioblastoma brain tumor has come back. The therapy combines an investigational drug (5-ALA) with focused ultrasound waves to target and damage tumor cells before surgery. The main goals are to check safety and see if …